Haag-Streit launches new and innovative Hess Screen app
Harlow, Essex (PRWEB UK) 28 August 2015 -- Haag-Streit UK (HS-UK), the leading manufacturer and distributor of gold-standard optometry and ophthalmic equipment, is pleased to announce the launch of the ‘Hess Test Lite’ App.
The ‘Hess Test Lite’ app provides a simple method for recording and documenting the function and co-ordination of the extra-ocular muscles in the standard Hess Chart notation. Using the Apple iPad, Hess Screen (and Lees Screen) results can be documented electronically within the Hess Test application, enabling the records to be stored and retrieved.
The app has been fully-validated for both reliability and repeatability. It allows the user to save all the patient data, along with relevant clinician information, and boasts some exciting features, including; a full 25-point Hess Screen documenting notation and an ’auto-connect’ function. This allows the user to auto-connect the response points, reducing the time needed for analysis.
Also included in the software is an integrated patient test results database and patient retrieval function, allowing a patients historical results to be reviewed and shared between interdisciplinary teams.
Sam Laidlaw, HS-UK Product Manager, said, “The Hess Chart is an essential tool in diagnosing and monitoring anomalies of the extra-ocular muscles. This innovative app enables customers to meet the increasing need to create electronic patient records, using software which can easily be combined into their daily clinical practice. The app also provides HS-UK with an excellent platform to develop further software solutions for the HS-UK product portfolio.”
To download the free Hess Screen app from iTunes, please visit http://hsuk.co/HessTestApp. For more information on the Hess Test Lite app, or to enquire about purchasing a Hess Screen, please call Haag-Streit UK on (01279) 883807, or email info(at)haag-streit-uk(dot)com.
Rebecca Herrett, Haag-Streit UK Limited, http://www.haagstreituk.com, +44 1279456260, [email protected]
Share this article